< 1 minute read
Oct. 6, 2021

Compound 18n: A Monocarboxylate Transporter 4 Inhibitor

"compound 18n"

monocarboxylate transporter 4 inhibitor in vivo PD but limited eff. in xenograft model from cell-based screen and opt. Journal of Medicinal Chemistry Merck Healthcare KGaA, Darmstadt, Germany

twitterlinkedinprintemail